Phathom Pharmaceuticals reports Preliminary Q4 results (PHAT:NASDAQ)

Press Room

2 months ago

Phathom Pharmaceuticals press release (PHAT): Q4 Net revenues of approximately $57 million to $58 million
- - GAAP operating expenses of approximately $59 million to $61 million
  - Non-GAAP operating expenses of approximately $51 million to $53 million, which excludes approximately $8 million of stock-based compensation